(Press-News.org) Opening up a new door in synthetic biology, a team of researchers has developed a microfluidic device that produces a continuous supply of tiny lipid spheres that are similar in many ways to a cell's outer membrane. "Cells are essentially small, complex bioreactors enclosed by phospholipid membranes," said Abraham Lee from the University of California, Irvine. "Effectively producing vesicles with lipid membranes that mimic those of natural cells is a valuable tool for fundamental biology research, and it's also an important first step in the hoped-for production of an artificial cell." The researchers have taken an important step in advancing this field by developing a single system that quickly and efficiently performs all the necessary steps to create stable lipid vesicles. Current multistep production methods create vesicles that have inconsistent sizes and layers and short usable lifespans, and they are often contaminated with solvents used in their production.
A paper accepted for publication in the AIP's journal.
Biomicrofluidics reports that the new microfluidic design overcomes these previous hurdles by generating and manipulating precisely sized droplets of water in an oil environment. This produces an oil-and-water membrane that serves as a scaffold around which lipids molecules assemble. As the membrane dissolves over time, the accumulated lipids form a stable, uniform vesicle that shares many of a natural cell membrane's chemical and physical attributes.
###
Article: "Stable, Biocompatible Lipid Vesicle Generation by Solvent Extraction-based Droplet Microfluidics" is accepted for publication in the journal Biomicrofluidics.
Authors: Shai-Yen The (1), Ruba Khnouf (2), Hugh Fan (2, 3), Abraham Lee (1, 4).
(1) Department of Biomedical Engineering, University of California at Irvine
(2) Department of Biomedical Engineering, University of Florida
(3) Department of Mechanical and Aerospace Engineering, University of Florida
(4) Department of Mechanical and Aerospace Engineering, University of California at Irvine
New device creates lipid spheres that mimic cell membranes
2011-12-19
ELSE PRESS RELEASES FROM THIS DATE:
New system may one day steer microrobots through blood vessels for disease treatment
2011-12-19
Microscopic-scale medical robots represent a promising new type of therapeutic technology. As envisioned, the microbots, which are less than one millimeter in size, might someday be able to travel throughout the human bloodstream to deliver drugs to specific targets or seek out and destroy tumors, blood clots, and infections that can't be easily accessed in other ways.
One challenge in the deployment of microbots, however, is developing a system to accurately "drive" them and maneuver them through the complex and convoluted circulatory system, to a chosen destination. ...
Close family ties keep microbial cheaters in check, study finds
2011-12-19
Any multicellular animal, from a blue whale to a human being, poses a special challenge for evolution.
Most of the cells in its body will die without reproducing; only a privileged few will pass their genes to the next generation.
How could the extreme degree of cooperation required by multicellular existence actually evolve? Why aren't all creatures unicellular individualists determined to pass on their own genes?
Joan Strassmann and David Queller, evolutionary biologists at Washington University in St. Louis, provide an answer in this week's issue of the journal ...
Following the crowd supports democracy
2011-12-19
This press release is available in German.
From shoals of fish to human society: social organisms need to make collective decisions. And it is not always the majority that prevails. In some cases, a small, resolute group may succeed in bending the whole community to their will. Using computer models and behavioural studies of fish, a team of scientists, including researchers from the Max Planck Institute for the Physics of Complex Systems in Dresden, has discovered that uninformed individuals support the decision of the majority and may prevent a particularly determined ...
Barracuda babies: Novel study sheds light on early life of prolific predator
2011-12-19
MIAMI -- For anglers and boaters who regularly travel the coasts of Florida the great barracuda (Sphyraena barracuda) is a common sight. Surprisingly, however, very little is known about the early life stage of this ecologically and socio-economically important coastal fish.
In the journal Marine Biology, lead author Dr. Evan D'Alessandro and University of Miami Rosenstiel School of Marine & Atmospheric Science colleagues Drs. Su Sponaugle, Joel Llopiz and Robert Cowen shed light on the larval stage of this ocean predator, as well as several other closely related species. ...
Protecting confidential data with math
2011-12-19
Statistical databases (SDBs) are collections of data that are used to gather and analyze information from a variety of sources. The data may be derived from sales transactions, customer files, voter registrations, medical records, employee rosters, product inventories, or other compilations of facts and figures.
Because database security requires multiple processes and controls, it presents huge security challenges to organizations. With the computerization of databases in healthcare, forensics, telecommunications, and other fields, ensuring this kind of security has ...
Cholesterol-lowering drugs may reduce mortality for influenza patients
2011-12-19
Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by the Journal of Infectious Diseases.
It is the first published observational study to evaluate the relationship between statin use and mortality in hospitalized patients with laboratory-confirmed influenza virus infection, according to Vanderbilt's William Schaffner, M.D., professor and chair of Preventive Medicine.
"We may be able to combine statins with antiviral drugs to provide better treatment for ...
Traumatic experiences may make you tough
2011-12-19
Your parents were right: Hard experiences may indeed make you tough. Psychological scientists have found that, while going through many experiences like assault, hurricanes, and bereavement can be psychologically damaging, small amounts of trauma may help people develop resilience.
"Of course, everybody's heard the aphorism, 'Whatever does not kill you makes you stronger,'" says Mark D. Seery of the University at Buffalo. His paper on adversity and resilience appears in the December issue of Current Directions in Psychological Science, a journal of the Association for ...
Quantum cats are hard to see
2011-12-19
Are there parallel universes? And how will we know? This is one of many fascinations people hold about quantum physics. Researchers from the universities of Calgary and Waterloo in Canada and the University of Geneva in Switzerland have published a paper this week in Physical Review Letters explaining why we don't usually see the physical effects of quantum mechanics.
"Quantum physics works fantastically well on small scales but when it comes to larger scales, it is nearly impossible to count photons very well. We have demonstrated that this makes it hard to see these ...
Tool enables scientists to uncover patterns in vast data sets
2011-12-19
With support from the National Science Foundation, researchers from the Broad Institute and Harvard University recently developed a tool that can uncover patterns in large data sets in a way that no other software program can.
Called Maximal Information Coefficient or MIC, the tool can can tease out multiple, recurring events or sets of data hidden in health information from around the globe, or in the changing bacterial landscape of the gut or even in statistics amassed from a season of competitive sports--and much more. The researchers report their findings in the Dec. ...
Spread of nasopharyngeal carcinoma is reduced by bevacizumab, according to phase 2 trial results
2011-12-19
The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.
Combining the widely used anti-cancer drug bevacizumab with standard chemoradiation therapy is safe and could prolong survival in patients with advanced nasopharyngeal carcinoma, according to a new phase 2 trial published Online First in today's The Lancet Oncology. The results indicate that bevacizumab might be more effective at preventing the spread of nasopharyngeal ...